Tctc Holdings, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Tctc Holdings, LLC
- $2.77 Billion
- Q1 2025
A detailed history of Tctc Holdings, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Tctc Holdings, LLC holds 19 shares of ALNY stock, worth $5,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$5,197% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
685Shares Held
109MCall Options Held
836KPut Options Held
784K-
Capital World Investors Los Angeles, CA16.6MShares$4.54 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$3.57 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.61 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.91 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.2 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...